Digitization has allowed Sanofi to optimize manufacturing and automate document preparation. And now, the firm predicts that ...

Agg-CLNP synergized with abatacept to delay RA-related inflammation and with dexamethasone to prevent flare-ups following ...

Cytiva will serve as the exclusive global distributor of Culture’s Stratyx 250 bioreactor platform and associated consumables.

This generally-regarded-as-safe yeast can be a cost-effective production vehicle for enzymes and antibodies, as well as heterologous proteins.

The speakers hope to stimulate conversation about how regions can remain competitive and while becoming interdependent.

As drug developers face mounting pressure to accelerate discovery timelines without sacrificing quality, QLNS-CHO offers a compelling solution.

HNF1A mutations are found to dysregulate RNA splicing in pancreatic cells, thereby contributing to the onset of diabetes.

Hypoxia may be a promising therapy path to address Parkinson's neurodegeneration caused by excessive oxygen levels in the brain.

Ocugen says it is on track to reshape the market for gene therapies against eye disorders over the next three years, by ...

A bacteria-based cancer therapy has been engineered that eradicates tumors in immunocompromised mice—no immune cells required.

In addition to cell line development, CHO Plus partnered to scale up Avid Bioservices' mAb production to meet industrial scale requirements.

Rare disease and gene therapy stocks, battered in recent months by clinical and commercial setbacks, will likely benefit from ...